- Home
- SLBT vs PHK Comparison
SLBT vs PHK Comparison
Compare SLBT & PHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | SLBT | PHK |
|---|---|---|
| Founded | N/A | 2003 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | | Finance/Investors Services |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 942.1M | 776.8M |
| IPO Year | 2025 | 2003 |
Fundamental Metrics
Financial Performance| Metric | SLBT | PHK |
|---|---|---|
| Price | $1.66 | $4.13 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 108.5K | ★ 1.4M |
| Earning Date | N/A | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.61% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.42 | $4.04 |
| 52 Week High | $6.25 | $5.00 |
Technical Indicators
Market Signals| Indicator | SLBT | PHK |
|---|---|---|
| Relative Strength Index (RSI) | 35.86 | 27.81 |
| Support Level | N/A | $4.04 |
| Resistance Level | $3.36 | $4.73 |
| Average True Range (ATR) | 0.18 | 0.08 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 32.89 | 11.76 |
Price Performance
Historical ComparisonAbout SLBT SL Science Holding Limited Ordinary Shares
SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.
About PHK Pimco High Income Fund
PIMCO High Income Fund is a closed-end management investment company. The company's primary investment objective is to seek high current income. Its portfolio management approach combines top-down macroeconomic analysis with fundamental credit research to identify attractive investment opportunities. The fund seeks to generate consistent income while actively managing interest rate, credit, and market risks.